https://orcid.org/0000-0002-6379-224X
References
- Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. Am Fam Physician. 2004;69(11):2599–2606.
- Salama OS, Al-Tonbary YA, Shahin RA, et al. Unbalanced bone turnover in children with β-thalassemia. Hematology. 2006;11(3):197–202. doi: 10.1080/10245330600702851
- Lal A, Fung EB, Pakbaz Z, et al. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer. 2006;47(7):901–906. doi: 10.1002/pbc.20681
- Perisano C, Marzetti E, Spinelli MS, et al. Physiopathology of bone modifications in β-thalassemia. Anemia. 2012;2012:1–5. doi: 10.1155/2012/320737
- Schündeln MM, Goretzki SC, Hauffa PK, et al. Impairment of bone health in pediatric patients with hemolytic anemia. PLoS One. 2014;9(10):e108400. doi: 10.1371/journal.pone.0108400
- Moreau R, Tshikudi Malu D, Dumais M, et al. Alterations in bone and erythropoiesis in hemolytic anemia: comparative study in bled, phenylhydrazine-treated and plasmodium-infected mice. PLoS One. 2012;7(9):e46101. doi: 10.1371/journal.pone.0046101
- Neyzi O, Gunoz H, Furman A, et al. Türk çocuklarında vücut ağırlığı, boy uzunluğu, baş çevresi ve vücut kitle indeksi referans değerleri. Çocuk Sağlığı ve Hastalıkları Dergisi. 2008;51:1–14.
- Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol. 2005;129(4):482–490. doi: 10.1111/j.1365-2141.2005.05476.x
- Haidar R, Musallam KM, Taher AT. Bone disease and skeletal complications in patients with β thalassemia major. Bone. 2011;48(3):425–432. doi: 10.1016/j.bone.2010.10.173
- Gordon CM, Leonard MB, Zemel BS. 2013 Pediatric position development conference: executive summary and reflections. J Clin Densitom. 2014;17:219–224. doi: 10.1016/j.jocd.2014.01.007
- Soyka LA, Fairfield WP, Klibanski A. Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab. 2000;85:3951–3963.
- Valderrábano RJ, Lui L-Y, Lee J, et al. Bone density loss Is associated with blood cell counts. J Bone Miner Res. 2017;32(2):212–220. doi: 10.1002/jbmr.3000
- Hofbauer LC, Khosla S, Dunstan CR, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000;15:2–12. doi: 10.1359/jbmr.2000.15.1.2
- Ambroszkiewicz J, Gajewska J, Laskowska-Klita T. Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender. Med Wieku Rozwoj. 2002;6(3):257–265.
- Seydewitz HH, Henschen M, Kuhnel W, et al. Pediatric reference ranges for osteocalcin measured by the immulite analyzer. Clin Chem Lab Med. 2001;39(10):980–982. doi: 10.1515/CCLM.2001.159
- Osunkwo I. An update on the recent literature on sickle cell bone disease. Curr Opin Endocrinol Diabetes Obes. 2013;20(6):539–546. doi: 10.1097/01.med.0000436192.25846.0b
- Giusti A, Pinto V, Forni GL, et al. Management of beta-thalassemia-associated osteoporosis. Ann N Y Acad Sci. 2016;1368(1):73–81. doi: 10.1111/nyas.13041
- Williams KM. Update on bone health in Pediatric chronic disease. Endocrinol Metab Clin North Am. 2016;45(2):433–441. doi: 10.1016/j.ecl.2016.01.009
- Wong P, Fuller PJ, Gillespie MT, et al. Thalassemia bone disease: A 19-year longitudinal analysis. J Bone Miner Res. 2014;29(11):2468–2473. doi: 10.1002/jbmr.2266